Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Options Exercise | $0 | +29.6K | +6.96% | $0.00 | 455K | Feb 1, 2024 | Direct | |
transaction | LLY | Common Stock | Tax liability | -$8.55M | -13.2K | -2.91% | $645.61 | 442K | Feb 1, 2024 | Direct | |
holding | LLY | Common Stock | 63.8K | Feb 1, 2024 | By David A. Ricks 2022 GRAT | ||||||
holding | LLY | Common Stock | 67.7K | Feb 1, 2024 | By David A. Ricks SLAT | F1 | |||||
holding | LLY | Common Stock | 7.22K | Feb 1, 2024 | 401(k) |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -29.6K | -100% | $0.00* | 0 | Feb 1, 2024 | Common Stock | 29.6K | Direct | F2 |
Id | Content |
---|---|
F1 | The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |